A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

NCT05365581 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

398

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Pancreatic Adenocarcinoma

Interventions

DRUG: ASP2138
DRUG: Pembrolizumab
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Fluorouracil
DRUG: Ramucirumab
DRUG: Paclitaxel
DRUG: Irinotecan
DRUG: Capecitabine

Sponsor

Astellas Pharma Global Development, Inc.